The amount of expense arising from reversal of equity-settled share-based payment transactions.

No definition available.

Name:	cntg_ExpenseFromReversalOfEquitySettledShareBasedPaymentTransactions
Namespace Prefix:	cntg_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number of equal tranches in which the granted RSU and options shall vest.

+ References

No definition available.

+ Details

Name:	cntg_NumberOfTranches
Namespace Prefix:	cntg_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of share based payment expense capitalized as transaction costs.

+ References

No definition available.

+ Details

Name:	cntg_ShareBasedPaymentExpenseCostsCapitalized
Namespace Prefix:	cntg_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of expense arising from reversal of share based payment transactions.

+ References

No definition available.

+ Details

Name:	cntg_ShareBasedPaymentTransactionsReversal
Namespace Prefix:	cntg_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The weighted average exercise price of other equity instruments (ie other than share options) exercised in a share-based payment arrangement.

+ References

No definition available.

+ Details

Name:	cntg_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement
Namespace Prefix:	cntg_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of expense arising from equity-settled share-based payment transactions in which the goods or services received did not qualify for recognition as assets. [Refer: Expense from share-based payment transactions]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 51
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_51_a&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- References

No definition available.

+ Details

Name:	ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.

+ References

+ Details

Name:	ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement.

+ References

+ Details

Name:	ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.

+ References

+ Details

Name:	ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	cntg_IfrsGranteeStatusAxis=cntg_Ifrs_shareBasedPaymentArrangementNonemployeeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	cntg_IfrsAwardTypeAxis=cntg_StockGrantAwardsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_ManagementBoardAndEmployeesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=cntg_SupervisoryBoardMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_EquityShareOption2019EquitySettledMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=cntg_LongTermIncentivePlanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	cntg_IfrsAwardTypeAxis=cntg_IfrsRestrictedStockUnitsRsusMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	cntg_IfrsGranteeStatusAxis=cntg_IfrsShareBasedPaymentArrangementEmployeeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Share-based payments - Other grants to management board, employees or other parties (Details) € in Thousands	12 Months Ended
	Dec. 31, 2023 EUR (€) shares item tranche	Dec. 31, 2023 item shares $ / shares	Dec. 31, 2022 EUR (€) Options shares	Dec. 31, 2021 EUR (€) Options
Expenses arising from share-based payment transactions
Reversals \| €	€ (187)		€ (3,244)
Total expenses arising from sharebased payment transactions \| €	2,929		(16)	€ 8,035
Share-Based Payment Arrangement, Nonemployee
Expenses arising from share-based payment transactions
Expenses arising from equity-settled share-based payment transactions \| €	€ 258
SGAs
Expenses arising from share-based payment transactions
RSUs granted	908,192
Number of shares forfeited	139,790
Number of other equity instruments outstanding in share-based payment arrangement	768,402	768,402
Management board and employees
Expenses arising from share-based payment transactions
Expenses arising from equity-settled share-based payment transactions \| €	€ 2,205		852	985
Supervisory board members
Expenses arising from share-based payment transactions
Expenses arising from equity-settled share-based payment transactions \| €				50
Equity share option 2019 (Equity settled)
Expenses arising from share-based payment transactions
Expenses arising from equity-settled share-based payment transactions \| €	€ 653		€ 2,376	€ 7,000
2019 Plan \| RSUs
Expenses arising from share-based payment transactions
RSUs granted \| Options				167,326
Number of units vested during the period	15,734		300,000
Number of other equity instruments outstanding in share-based payment arrangement \| item	17,676	17,676
2019 Plan \| SGAs
Expenses arising from share-based payment transactions
RSUs granted	908,192		425,093
Number of other equity instruments outstanding in share-based payment arrangement	209,017	209,017
2019 Plan \| SGAs \| Ifrs Share based payment arrangement employee
Expenses arising from share-based payment transactions
RSUs granted	224,414
Number of shares forfeited	8,392
Number of units vested during the period	144,184
Number of Tranches \| tranche	1
Exercised during the year \| $ / shares		$ 1.14
Number of other equity instruments outstanding in share-based payment arrangement	68,838	68,838
2019 Plan \| SGAs \| Share-Based Payment Arrangement, Nonemployee
Expenses arising from share-based payment transactions
RSUs granted	400,000
Costs capitalized \| €	€ 202
Number of Tranches \| tranche	1
Exercised during the year \| $ / shares		$ 1.14